PodcastsSalud y forma físicaThe Bob Harrington Show

The Bob Harrington Show

Medscape
The Bob Harrington Show
Último episodio

75 episodios

  • The Bob Harrington Show

    Stroke, Dementia, Voodoo Death: The Heart-Brain Connection

    26/01/2026 | 23 min
    Cardiologist Bob Harrington talks to Mitch Elkind, chief science officer for Brain Health and Stroke at the AHA, about the heart-brain connection and why what's good for the brain is good for the heart.
    This podcast is intended for healthcare professionals only.
    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington
    Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association  https://www.ahajournals.org/doi/10.1161/CIR.0000000000001078
    Migraine Headache: An Under-Appreciated Risk Factor for Cardiovascular Disease in Women https://www.ahajournals.org/doi/10.1161/JAHA.119.014546
    Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands
    https://doi.org/10.1080/13814788.2017.1398318
    Characteristics and treatment of midlife-onset epilepsy: A 24-year single-center, retrospective study
    https://doi.org/10.1002/epd2.20253
    Traumatic Brain Injury and Risk of Neurodegenerative Disorder
    https://doi.org/10.1016/j.biopsych.2021.05.025
    Cardiac Changes in Parkinson's Disease: Lessons from Clinical and Experimental Evidence
    https://doi.org/10.3390/ijms222413488
    The neuropathological diagnosis of Alzheimer's disease
    https://doi.org/10.1186/s13024-019-0333-5
    Failed Semaglutide for Early Alzheimer's Not the End of the Road?
    https://www.medscape.com/viewarticle/failed-semaglutide-early-alzheimers-not-end-road-2025a1000y4l
    Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration
    https://doi.org/10.1161/circulationaha.121.055018
    Reduced regional cerebral blood flow in patients with heart failure
    https://doi.org/10.1002/ejhf.874
    Heart-brain Interactions in Heart Failure
    https://doi.org/10.15420/cfr.2018.14.2
    While You Were Sleeping, the Brain's 'Waste Disposal System' Was at Work
    https://www.medscape.com/viewarticle/while-you-were-sleeping-brains-waste-disposal-system-was-2025a1000mbb
    Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder
    https://doi.org/10.1001/jamapsychiatry.2024.3599
    2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines https://www.ahajournals.org/doi/10.1161/CIR.0000000000001356
    "VOODOO" Death https://ajph.aphapublications.org/doi/full/10.2105/AJPH.92.10.1593
    Longitudinal brain ageing after stroke: a marker for neurodegeneration and its relevance for upper limb motor outcome https://doi.org/10.1093/braincomms/fcaf299
    Unlocking Longevity: Aging Reimagined  https://www.medscape.com/viewarticle/1002241
    You may also like:
    Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology
    https://www.medscape.com/twic
    Questions or feedback, please contact [email protected]
  • The Bob Harrington Show

    Cardiovascular Medicine 2025 Wrapped: The Big Picture

    30/12/2025 | 31 min
    Drs Harrington and Gibson's annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ever lower LDL-C with drugs or even gene editing are among the highlights.
    This podcast is intended for healthcare professionals only.
    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington
    New ACS Guidelines
    2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
    https://doi.org/10.1161/CIR.0000000000001309
    ACS Guideline Chair and Vice-Chair Discussion
    https://www.medscape.com/viewarticle/acs-guidelines-2025-key-points-chair-and-vice-chair-2025a100093l
    Antiplatelet/Antithrombotic Strategies
    Prasugrel Beats Ticagrelor in High-Risk Patients With Diabetes After PCI
    https://www.medscape.com/viewarticle/prasugrel-beats-ticagrelor-high-risk-patients-diabetes-after-2025a1000wbt
    Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET)
    https://www.nejm.org/doi/full/10.1056/NEJMoa2507980
    Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC)
    https://www.nejm.org/doi/full/10.1056/NEJMoa2507532
    Bayesian Machine Learning Model Guiding Iterative, Personalized Anticoagulant Dosing Decision-Making : ENGAGE AF-TIMI 48 Trial Analysis
    https://doi.org/10.1016/j.jacadv.2025.102504
    Factor XI Inhibitors
    Bristol Myers, J&J Stop Blood Clotting Drug Trial After Interim Review
    https://www.medscape.com/s/viewarticle/bristol-myers-j-j-stop-blood-clotting-drug-trial-after-2025a1000vqu
    Bayer's Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention https://www.bayer.com/en/us/news-stories/oceanic-stroke
    OAC-Naive Subgroup From OCEANIC-AF Published
    https://www.medscape.com/viewarticle/novel-blood-thinner-shows-promise-atrial-fibrillation-2025a10008lz
    GLP-1 and Myotrophic Drugs
    Lilly's Next-gen Drug Shows Greater Weight Loss Than Zepbound in Late-stage Trial (TRIUMPH-4)
    https://www.medscape.com/s/viewarticle/lillys-next-gen-drug-tops-zepbound-weight-loss-late-stage-2025a1000ys1
    Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial
    https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf
    CRISPR and Lipid Lowering
    Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
    https://www.nejm.org/doi/full/10.1056/NEJMoa2504747
    Gene Therapy Shows Lipid Improvement but Raises Flags
    https://www.medscape.com/viewarticle/gene-therapy-shows-lipid-improvement-raises-flags-2025a1000uzw
    Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
    https://www.nejm.org/doi/full/10.1056/NEJMoa2511778
    Evolocumab in Patients without a Previous Myocardial Infarction or Stroke (VESALIUS-CV)
    https://www.nejm.org/doi/pdf/10.1056/NEJMoa2514428
    Prehospital GLP IIb/IIIa
    Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction (CELEBRATE) https://evidence.nejm.org/doi/full/10.1056/EVIDoa2500268
    You may also like:
    Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology
    https://www.medscape.com/twic
    Questions or feedback, please contact [email protected]
  • The Bob Harrington Show

    SMuRF-less: CV Prevention Beyond Traditional Risk Factors

    29/10/2025 | 24 min
    Drs Harrington, Rodriguez, and Ridker discuss the changing field of cardiac prevention, where imaging fits in, and the new concept of standard modifiable risk factor-less patients.
    This podcast is intended for healthcare professionals only.
    To read a transcript or to comment, visit
    https://www.medscape.com/author/bob-harrington
    Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
    https://doi.org/10.1161/CIR.0000000000001078
    Development and Validation of the American Heart Association's PREVENT Equations
    https://doi.org/10.1161/CIRCULATIONAHA.123.067626
    C-Reactive Protein and Cardiovascular Risk Among Women With No Standard Modifiable Risk Factors: Evaluating the 'Smurf-Less but Inflamed'
    https://doi.org/10.1093/eurheartj/ehaf658
    Mortality in STEMI Patients Without Standard Modifiable Risk Factors: A Sex-Disaggregated Analysis of SWEDEHEART Registry Data
    https://doi.org/10.1016/S0140-6736(21)00272-5
    Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
    https://www.nejm.org/doi/10.1056/NEJMoa2405182
    Statins for the 'SMuRFLess But Inflamed': Silent Vascular Inflammation and the Challenge of Translational Science
    https://doi.org/10.1016/j.jacbts.2025.101318
    VERVE-101: A Promising CRISPR-Based Gene Editing Therapy That Reduces LDL-C and PCSK9 Levels in HeFH Patients
    https://academic.oup.com/ehjcvp/article/10/2/89/7492807
    You may also like:
    Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology
    https://www.medscape.com/twic
    Questions or feedback, please contact [email protected]
  • The Bob Harrington Show

    Unlocking Longevity: Aging Reimagined

    07/10/2025 | 22 min
    Cardiologist and author Eric Topol discusses the science of longevity, why the key to healthy aging is prevention, and the perils of a fixation on reversing ageing.
    This podcast is intended for healthcare professionals only.
    To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington
    Super Agers: An Evidence-Based Approach to Longevity
    https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
    Wellderly study
    https://www.scripps.edu/science-and-medicine/translational-institute/translational-research/genomic-medicine/wellderly/
    Lotte Bjerre Knudsen
    https://erictopol.substack.com/p/lotte-bjerre-knudsen-the-scientist
    Organ aging signatures in the plasma proteome track health and disease
    https://doi.org/10.1038/s41586-023-
    Deep Medicine
    https://drerictopol.com/portfolio/deep-medicine/
    You may also like:
    Hear John Mandrola, MD, give a summary and his perspective on the top cardiology news each week, on This Week in Cardiology
    https://www.medscape.com/twic
    Questions or feedback, please contact [email protected]
  • The Bob Harrington Show

    Nobel Laureate on Touch and the Joy of Scientific Discovery

    15/09/2025 | 23 min
    The 2021 winner of the Nobel Prize in medicine, Ardem Patapoutian speaks of his love for science, why he wishes he had an MD, and the importance of getting out of the lab to inspire young people.
    This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit:
    https://www.medscape.com/author/bob-harrington
    Nobel Prize in Physiology or Medicine 2021
    https://pubmed.ncbi.nlm.nih.gov/39429349/
    https://www.nobelprize.org/prizes/medicine/2021/press-release/
    Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels https://pubmed.ncbi.nlm.nih.gov/20813920/
    PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex
    https://doi.org/10.1126/science.aau6324
    PIEZO Ion Channels in Cardiovascular Functions and Diseases
    https://doi.org/10.1161/CIRCRESAHA.123.322798
    You may also like:
    Hear John Mandrola, MD, with his summary and perspective on the top cardiology news each week, on This Week in Cardiology
    https://www.medscape.com/twic
    Questions or feedback, please contact
    [email protected]

Más podcasts de Salud y forma física

Acerca de The Bob Harrington Show

The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.
Sitio web del podcast

Escucha The Bob Harrington Show, Diario de un Humano y muchos más podcasts de todo el mundo con la aplicación de radio.net

Descarga la app gratuita: radio.net

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app

The Bob Harrington Show: Podcasts del grupo

  • Podcast This Week in Cardiology
    This Week in Cardiology
    Ciencias, Salud y forma física, Medicina
Aplicaciones
Redes sociales
v8.7.2 | © 2007-2026 radio.de GmbH
Generated: 3/15/2026 - 9:00:56 PM